EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Follicular lymphoma grade 3A: aggressiveness and curability in an Asian cohort of 781 patients

Yaoyao Jing, Donghui Xing, Bo Yang, Yong Yu, Haifeng Zhao, Hongliang Yang, Yafei Wang, Bei Sun, Xiaofang Wang

Annals of Hematology · 2025

DOI: 10.1007/s00277-025-06349-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, 2025. Verfasst von Yaoyao Jing und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Day Ward, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Lymphoma, Follicular, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Follicular lymphoma grade 3A (FL3A) is an uncommon subtype of FL with histology falling between FL grade 1/2 (FL1/2) and FL grade 3B (FL3B). The behavior of FL3A is currently debated, with some studies suggesting it may be potentially curable while others deem it incurable. However, the lack of large-scale studies with prolonged follow-up and changes in prognosis due to the use of rituximab (R) call for further investigation into the clinical course, prognosis, and treatment of FL3A in the R era. We conducted a follow-up for a median of 7.3 years (30% exceeded 10 years) on 104 FL3A cases who received R-CHOP/R-CHOP-like treatment. We compared the characteristics, clinical behavior, and prognosis of the FL3A group with control groups of DLBCL (n = 478), FL3B (n = 45), and FL1/2 (n = 154). Based on R-CHOP/like therapy, FL3A had similar outcomes to FL3B and DLBCL, with comparable 5-year and 10-year PFS and OS rates. Follow-up revealed that both FL3A and FL3B showed PFS platform 6 years after treatment initiation, while DLBCL had low recurrence rates (< 2%) after 5 years. FL1/2 showed persistent recurrence. No significant difference was observed in PFS among the four groups (p = 0.955) (Fig. 2A). Based on R-CHOP/R-CHOP-like regimen treatment, the OS of FL3A, FL3B and DLBCL manifested no statistically significant differences (p = 0.812), although FL3A appears to exhibit the poorest long-term survival in the curve, but FL1/2 showed better OS than the other three groups (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, FollicularAntineoplastic Combined Chemotherapy ProtocolsHumansMaleFemaleMiddle AgedVincristineRituximabAgedDoxorubicinPrednisoneAdultCyclophosphamideFollow-Up StudiesNeoplasm GradingAged, 80 and overAsian PeopleLymphoma, Large B-Cell, DiffuseCohort StudiesRetrospective StudiesPrognosisSurvival Rate

Stichwörter der Autor:innen

AnthracyclinesDiffuse large B-cell lymphomaFollicular lymphomaGrade 3ARituximab

Substanzen

VincristineRituximabDoxorubicinPrednisoneCyclophosphamideR-CHOP protocol

Autor:innen und Institutionen

  • Department of Day Ward, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China.
  • Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.
  • Tianjin's Clinical Research Center for Cancer, Tianjin, China.
  • Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
  • Department of Hematology, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China.
  • Department of Pathology, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China.

Zitieren

APA

Jing, Y., Xing, D., Yang, B., Yu, Y., Zhao, H., Yang, H., Wang, Y., Sun, B., & Wang, X. (2025). Follicular lymphoma grade 3A: aggressiveness and curability in an Asian cohort of 781 patients. Annals of Hematology. https://doi.org/10.1007/s00277-025-06349-3

Vancouver

Jing Y, Xing D, Yang B, Yu Y, Zhao H, Yang H, et al. Follicular lymphoma grade 3A: aggressiveness and curability in an Asian cohort of 781 patients. Annals of Hematology. 2025. doi:10.1007/s00277-025-06349-3

BibTeX
@article{Jing2025,
  author = {Jing, Yaoyao and Xing, Donghui and Yang, Bo and Yu, Yong and Zhao, Haifeng and Yang, Hongliang and Wang, Yafei and Sun, Bei and Wang, Xiaofang},
  title = {Follicular lymphoma grade 3A: aggressiveness and curability in an Asian cohort of 781 patients},
  journal = {Annals of Hematology},
  year = {2025},
  doi = {10.1007/s00277-025-06349-3}
}
Kostenlos starten →